Cover Image
市場調查報告書

家庭注射療法市場分析:各產品 (輸液幫浦、靜脈注射套組、IV針頭、無針式接頭),各用途,及至2022年的市場區隔預測

Home Infusion Therapy Market Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application And Segment Forecasts To 2022

出版商 Grand View Research, Inc. 商品編碼 342348
出版日期 內容資訊 英文 87 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
家庭注射療法市場分析:各產品 (輸液幫浦、靜脈注射套組、IV針頭、無針式接頭),各用途,及至2022年的市場區隔預測 Home Infusion Therapy Market Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application And Segment Forecasts To 2022
出版日期: 2015年04月20日 內容資訊: 英文 87 Pages
簡介

全球家庭注射療法市場預計至2022年達到319億美元。慢性疾病的發病率上升擴大了門診病人對注射療法的需求。還有全球的高齡化也成為擴大市場的一大要素。

本報告提供全球家庭注射療法市場相關分析,各產品,各用途預測,以及各地區趨勢等彙整資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 家庭注射療法產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 被優先的主要的機會
  • 產業分析:波特
  • PESTEL分析
  • 未滿足需求分析

第4章 產品預測

  • 各產品市場佔有率
  • 輸液幫浦
  • 靜脈注射套組
  • 無針式接頭

第5章 各用途預測

  • 各用途市場佔有率
  • 抗發炎
  • 水和療法
  • 化療
  • 經腸營養
  • 非口服營養
  • 特殊醫藥品
  • 其他

第6章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭環境

  • Terumo Corporation
  • B. Braun Melsungen
  • Caesarea Medical Electronics
  • Smiths Medical
  • CareFusion Corporation
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • Baxter Inc
  • Fresenius Kabi

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-389-8

Global Home Infusion Therapy Market is expected to reach USD 31.9 billion by 2022, according to a new study by Grand View Research Inc. Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings.

Further key findings from the study suggest:

Needleless connectors are expected to witness lucrative growth over the forecast period. Growing demand for enhanced healthcare service provider safety has led to the rise in demand for needleless connectors.

Anti-Infective dominated the market with a revenue share of over 25.0% in 2014. Home administration of anti-infective therapy is preferred by patients who have chronic infections that cannot be treated through oral agents. It is considered as the most user friendly home infusion therapy.

North America accounted for more than 40% of the home infusion therapy market in 2014 on account of the presence of large geriatric population base. Presence of sophisticated healthcare infrastructure and favorable reimbursement plans laid out by regulatory bodies are also expected to make significant contributions towards market growth.

Asia Pacific is expected to emerge as a high growth market over the forecast period. Presence of large unmet needs in the emerging economies such as China and India. Rising patient awareness levels regarding the benefits of home infusion therapies over the in-hospital infusion therapies is expected to further boost the growth of this region.

Key players of home infusion therapy market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, CareFusion Corporation and Hospira Inc. Mergers and acquisitions and entering into strategic collaborations with healthcare providers are two key sustainability strategies adopted by these market participants.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumption
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Home Infusion Therapy - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. Home Infusion Therapy Industry Outlook

  • 3.1. Home infusion therapy market segmentation
  • 3.2. Home infusion therapy market size and growth prospects
  • 3.3. Home infusion therapy market dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Home infusion therapy market PESTEL analysis, 2014
  • 3.7. Home infusion therapy - Unmet need analysis

Chapter 4. Home Infusion Therapy Product Outlook

  • 4.1. Home infusion therapy market share by product, 2014 & 2022
  • 4.2. Infusion pumps
    • 4.2.1. Infusion pumps market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.3. Intravenous sets
    • 4.3.1. Intravenous sets market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.4. Needleless connectors
    • 4.4.1. Needleless connectors market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 5. Home Infusion Therapy Application Outlook

  • 5.1. Home infusion therapy market share by application, 2014 & 2022
  • 5.2. Anti-infective
    • 5.2.1. Anti-infective market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.3. Hydration therapy
    • 5.3.1. Hydration therapy market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Chemotherapy market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.5. Enteral Nutrition
    • 5.5.1. Enteral nutrition market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.6. Parenteral nutrition
    • 5.6.1. Parenteral nutrition market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.7. Specialty pharmaceuticals
    • 5.7.1. Specialty pharmaceuticals market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 6. Home infusion therapy Regional Outlook

  • 6.1. Home infusion therapy market share by region, 2014 & 2022
  • 6.2. North America
    • 6.2.1. North America home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
      • 6.2.1.1. U.S. market estimates and forecasts
      • 6.2.1.2. Canada market estimates and forecasts
    • 6.2.2. North America home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
      • 6.2.2.1. U.S. market estimates and forecasts
      • 6.2.2.2. Canada market estimates and forecasts
  • 6.3. Europe
    • 6.3.1. Europe home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
      • 6.3.1.1. Germany market estimates and forecasts
      • 6.3.1.2. UK market estimates and forecasts
    • 6.3.2. Europe home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
      • 6.3.2.1. Germany market estimates and forecasts
      • 6.3.2.2. UK market estimates and forecasts
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
      • 6.4.1.1. China market estimates and forecasts
      • 6.4.1.2. Japan market estimates and forecasts
    • 6.4.2. Asia Pacific home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
      • 6.4.2.1. China market estimates and forecasts
      • 6.4.2.2. Japan market estimates and forecasts
  • 6.5. Latin America
    • 6.5.1. Latin America home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
    • 6.5.2. Latin America home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
    • 6.6.2. MEA home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Terumo Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. B. Braun Melsungen
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Caesarea Medical Electronics
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. Smiths Medical
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. CareFusion Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Financial Performance
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Initiatives
  • 7.6. ICU Medical Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. JMS Co. Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. Baxter Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
  • 7.9. Fresenius Kabi
    • 7.9.1. Company Overview
    • 7.9.2. Financial Performance
    • 7.9.3. Product Benchmarking
    • 7.9.4. Strategic Initiatives

List of Tables

  • 1. Home Infusion Therapy- Industry Summary and Key Buying Criteria
  • 2. Home Infusion Therapy Market by Product, (USD million), 2012 - 2022
  • 3. Home Infusion Therapy Market by Application, (USD million), 2012 - 2022
  • 4. Home Infusion Therapy Market by Region, (USD million), 2012 - 2022
  • 5. Home Infusion Therapy Market - Key market drivers analysis
  • 6. Home Infusion Therapy Market - Key market restraints analysis
  • 7. Infusion Pumps Market, 2012 to 2022 (USD million)
  • 8. Intravenous Sets Market, 2012 to 2022 (USD million)
  • 9. IV Cannulas Market, 2012 to 2022 (USD million)
  • 10. Needle Less Connectors Market, 2012 to 2022 (USD million)
  • 11. Anti-Infective Market, 2012 to 2022 (USD million)
  • 12. Hydration Therapy Market, 2012 to 2022 (USD million)
  • 13. Chemotherapy Market, 2012 to 2022 (USD million)
  • 14. Enteral Nutrition Market, 2012 to 2022 (USD million)
  • 15. Parenteral Nutrition Market, 2012 to 2022 (USD million)
  • 16. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
  • 17. Others Market, 2012 to 2022 (USD million)
  • 18. Global Home Infusion Therapy Market, By Region, 2012 to 2022 (USD million)
  • 19. North America Home Infusion Therapy Demand, By Product, (USD million), 2012 - 2022
  • 20. North America Home Infusion Therapy Demand, By Application, (USD million), 2012 - 2022
  • 21. Europe Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 22. Europe Home Infusion Therapy Demand, By Applications, (USD million), 2012 - 2022
  • 23. Asia Pacific Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 24. Asia Pacific Home Infusion Therapy Demand, By Applications, (USD million), 2012 - 2022
  • 25. Latin America Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 26. Latin America Home Infusion Therapy Demand, By Application, (USD million), 2012 - 2022
  • 27. MEA Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 28. MEA Home Infusion Therapy Demand, By Application, (USD million), 2012 - 2022

List of Figures

  • 1. Home Infusion Therapy Market Segmentation
  • 2. Global Home Infusion Therapy Market Revenue, 2012 - 2022
  • 3. Home Infusion Therapy Market Dynamics
  • 4. Key Opportunities Prioritized
  • 5. Industry Analysis - Porter's
  • 6. Home Infusion Therapy PESTEL Analysis, 2012
  • 7. Global Home Infusion Therapy Market , By Product, (USD million), 2012 - 2022
  • 8. Infusion Pumps Market, 2012 to 2022 (USD million)
  • 9. Intravenous Sets Market, 2012 to 2022 (USD million)
  • 10. IV Cannulas Market, 2012 to 2022 (USD million)
  • 11. Needleless Connectors Market, 2012 to 2022 (USD million)
  • 12. Global Home Infusion Therapy Market , By Application, (USD million), 2012 - 2022
  • 13. Anti-Infective Market, 2012 to 2022 (USD million)
  • 14. Hydration Therapy Market, 2012 to 2022 (USD million)
  • 15. Chemotherapy Market, 2012 to 2022 (USD million)
  • 16. Enteral Nutrition Market, 2012 to 2022 (USD million)
  • 17. Parenteral Nutrition Market, 2012 to 2022 (USD million)
  • 18. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
  • 19. Others Market, 2012 to 2022 (USD million)
  • 20. Global Home Infusion Therapy Market, By Region 2012 to 2022 (USD million)
  • 21. Infusion Pumps Market, 2012 to 2022 (USD million)
  • 22. Intravenous Sets Market, 2012 to 2022 (USD million)
  • 23. IV Cannulas Market, 2012 to 2022 (USD million)
  • 24. Needleless Connectors Market, 2012 to 2022 (USD million)
  • 25. Anti-Infective Market, 2012 to 2022 (USD million)
  • 26. Hydration Therapy Market, 2012 to 2022 (USD million)
  • 27. Chemotherapy Market, 2012 to 2022 (USD million)
  • 28. Enteral Nutrition Market, 2012 to 2022 (USD million)
  • 29. Parenteral Nutrition Market, 2012 to 2022 (USD million)
  • 30. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
  • 31. Others Market, 2012 to 2022 (USD million)
  • 32. Home Infusion Therapy market - Company market share analysis, 2014 (%)
Back to Top